Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers AG Unsponsored ADR (SMMNY)
OTHER OTC:SMMNY
SMMNY Stock Chart & Stats
$28.03
--
Market closed
$28.03
--
Day’s Range― - ―
52-Week Range$23.42 - $30.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)5.73K
Market Cap
$62.84B
Enterprise Value$77.92B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.4
Beta0.97
Next Earnings
Nov 05, 2025EPS Estimate
0.4Last Dividend Ex-Date
Feb 20, 2025Dividend Yield1.85%
Share Statistics
EPS (TTM)0.37
Shares Outstanding2,256,000,000
10 Day Avg. Volume4,563
30 Day Avg. Volume5,726
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.24
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
Siemens Healthineers AG Unsponsored ADR News
SMMNY FAQ
What was Siemens Healthineers AG Unsponsored ADR’s price range in the past 12 months?
Siemens Healthineers AG Unsponsored ADR lowest stock price was $23.42 and its highest was $30.26 in the past 12 months.
What is Siemens Healthineers AG Unsponsored ADR’s market cap?
Siemens Healthineers AG Unsponsored ADR’s market cap is $62.84B.
When is Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date?
Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date is Nov 05, 2025 which is in 3 days.
How were Siemens Healthineers AG Unsponsored ADR’s earnings last quarter?
Siemens Healthineers AG Unsponsored ADR released its earnings results on Jul 30, 2025. The company reported $0.367 earnings per share for the quarter, beating the consensus estimate of $0.311 by $0.056.
Is Siemens Healthineers AG Unsponsored ADR overvalued?
According to Wall Street analysts Siemens Healthineers AG Unsponsored ADR’s price is currently Overvalued.
Does Siemens Healthineers AG Unsponsored ADR pay dividends?
Siemens Healthineers AG Unsponsored ADR pays a Annually dividend of $0.521 which represents an annual dividend yield of 1.85%. See more information on Siemens Healthineers AG Unsponsored ADR dividends here
What is Siemens Healthineers AG Unsponsored ADR’s EPS estimate?
Siemens Healthineers AG Unsponsored ADR’s EPS estimate is 0.4.
How many shares outstanding does Siemens Healthineers AG Unsponsored ADR have?
Siemens Healthineers AG Unsponsored ADR has 2,256,000,000 shares outstanding.
What happened to Siemens Healthineers AG Unsponsored ADR’s price movement after its last earnings report?
Siemens Healthineers AG Unsponsored ADR reported an EPS of $0.367 in its last earnings report, beating expectations of $0.311. Following the earnings report the stock price went up 1.609%.
Which hedge fund is a major shareholder of Siemens Healthineers AG Unsponsored ADR?
Currently, no hedge funds are holding shares in SMMNY
Siemens Healthineers AG Unsponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.36%
12-Months-Change
Fundamentals
Return on Equity
11.75%
Trailing 12-Months
Asset Growth
4.77%
Trailing 12-Months
Company Description
Siemens Healthineers AG Unsponsored ADR
Siemens Healthineers AG Unsponsored ADR (SMMNY) is a global leader in medical technology and healthcare solutions, providing innovative and high-quality products and services in the fields of imaging, diagnostics, and digital health. The company operates primarily in the healthcare sector, focusing on areas such as imaging systems (including MRI, CT, and ultrasound), laboratory diagnostics, and advanced therapies. Siemens Healthineers aims to enhance patient care by delivering cutting-edge technologies and solutions that improve clinical outcomes and operational efficiency in healthcare settings.
SMMNY Company Deck
SMMNY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in key segments like Imaging and Varian, with significant revenue and EPS growth, leading to a positive outlook revision. However, challenges such as tariff impacts and market issues in China were noted. Despite these challenges, the company's robust performance and strategic advancements contribute to a positive sentiment.View all SMMNY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---